NORWOOD, MA: Resunab Significantly Decreased Fibrotic Response and Exerted Potent Anti-Fibrotic Effects in Bleomycin-Induced Lung Fibrosis When Administered During Early and Later Stages of Fibrogenesis; Poster Pr ...
BEVERLY, MA: Cellceutix Meeting With FDA to Discuss Phase 2 Clinical Trial for Ulcerative Proctitis Treatment; Cellceutix's Abstract on Kevetrin to Be Presented at ASCO
...
LAVAL, QUEBEC: - 2014 revenues of $23.0 million and net profit of $2.6 million, Q4 2014 revenues of $10.5 million with net profit of $8.5 million - Initiation of 3 different PBI-4050 clinical programs in patients su ...
TUSTIN, CA: Optimizing Purification Techniques to Remove Process-Related Impurities With No Impact on Critical Quality Attributes; Strategies for Developing Process-Specific Host Cell Protein Antigens That Can Be ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.